cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Inovio Pharmaceuticals Inc
131 own
88 watching
Current Price
$2.26
$0.06
(2.73%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
176.82M
52-Week High
52-Week High
14.75
52-Week Low
52-Week Low
1.74000
Average Volume
Average Volume
0.69M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization176.82M
icon52-Week High14.75
icon52-Week Low1.74000
iconAverage Volume0.69M
iconDividend Yield--
iconP/E Ratio--
What does the Inovio Pharmaceuticals Inc do?
Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. Its SynCon immunotherapy design has the ability to break the immune system's tolerance of cancerous cells; and SynCon product design is also intended to facilitate cross-strain protection against known, as well as new unmatched strains of pathogens, such as influenza. It has completed, current or planned clinical programs of its proprietary SynCon immunotherapies for HPV-caused pre-cancers and cancers, influenza, prostate cancer, breast/lung/pancreatic cancer, hepatitis C virus, hepatitis B virus, HIV, Ebola, Middle East Respiratory Syndrome, and Zika virus. The company's partners and collaborators include MedImmune, LLC, the Wistar Institute, University of Pennsylvania, Defense Advanced Research Projects Agency, GeneOne Life Science, Plumbline Life Sciences, ApolloBio Corporation, Drexel University, the National Institutes of Health, HIV Vaccines Trial Network, National Cancer Institute, and U.S. Military HIV Research Program. Inovio Pharmaceuticals, Inc. was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.
Read More
How much money does Inovio Pharmaceuticals Inc make?
News & Events about Inovio Pharmaceuticals Inc.
PR Newswire
1 year ago
INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference INOVIO to Present at the 2023 RBC Capital Markets Global Healthcare Conference PR Newswire PLYMOUTH MEETING, Pa., May 5, 2023 PLYMOUTH MEETING, Pa., May 5, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology...
PR Newswire
1 year ago
INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023 INOVIO to Report First Quarter 2023 Financial Results on May 10, 2023 PR Newswire PLYMOUTH MEETING, Pa., April 28, 2023 PLYMOUTH MEETING, Pa., April 28, 2023 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused...
Fool.com Headlines
1 year ago
The company will present an abstract for its Ebola vaccine booster this month.Shares of Inovio Pharmaceuticals (NASDAQ: INO) were up 20% early Thursday afternoon after the biotech company announced that it will present its abstract for INO-4201 as an Ebola booster for rVSV-ZEBOV (Ervebo) at the 33rd...
PR Newswire
1 year ago
INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo) at ECCMID 2023 INOVIO Announces Acceptance of Abstract for Oral Presentation on INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo) at ECCMID 2023 PR Newswire PLYMOUTH MEETING...
PR Newswire
1 year ago
INOVIO to Present at the Oppenheimer 33rd Annual Healthcare Conference INOVIO to Present at the Oppenheimer 33rd Annual Healthcare Conference PR Newswire PLYMOUTH MEETING, Pa., March 3, 2023 PLYMOUTH MEETING, Pa., March 3, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on...
Frequently Asked Questions
Frequently Asked Questions
What is Inovio Pharmaceuticals Inc share price today?
plus_minus_icon
Can Indians buy Inovio Pharmaceuticals Inc shares?
plus_minus_icon
How can I buy Inovio Pharmaceuticals Inc shares from India?
plus_minus_icon
Can Fractional shares of Inovio Pharmaceuticals Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Inovio Pharmaceuticals Inc stocks?
plus_minus_icon
What is today’s traded volume of Inovio Pharmaceuticals Inc?
plus_minus_icon
What is today’s market capitalisation of Inovio Pharmaceuticals Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Inovio Pharmaceuticals Inc?
plus_minus_icon
What percentage is Inovio Pharmaceuticals Inc down from its 52-Week High?
plus_minus_icon
What percentage is Inovio Pharmaceuticals Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$2.26
$0.06
(2.73%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Coherus BioSciences Inc
Coherus BioSciences Inc
$1.31
$-0.01 (-0.76 %)
MacroGenics, Inc.
MacroGenics, Inc.
$3.09
$0.09 (2.84 %)
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc.
$1.80
$0.10 (6.18 %)
Cellectis S.A.
Cellectis S.A.
$1.54
$0.03 (2.32 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Coherus BioSciences Inc
Coherus BioSciences Inc
$1.31
$-0.01 (-0.76 %)
MacroGenics, Inc.
MacroGenics, Inc.
$3.09
$0.09 (2.84 %)
Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc.
$1.80
$0.10 (6.18 %)
Cellectis S.A.
Cellectis S.A.
$1.54
$0.03 (2.32 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00